These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 27680991)

  • 1. Public health economic evaluation of different European Union-level policy options aimed at reducing population dietary trans fat intake.
    Martin-Saborido C; Mouratidou T; Livaniou A; Caldeira S; Wollgast J
    Am J Clin Nutr; 2016 Nov; 104(5):1218-1226. PubMed ID: 27680991
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Estimated health benefits, costs, and cost-effectiveness of eliminating industrial trans-fatty acids in Australia: A modelling study.
    Marklund M; Zheng M; Veerman JL; Wu JHY
    PLoS Med; 2020 Nov; 17(11):e1003407. PubMed ID: 33137090
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development and application of the TFA macrosimulation model: a case study of modelling the impact of trans fatty acid (TFA) elimination policies in Brazil.
    Nilson EAF; Khandpur N; da Silva Gomes F
    BMC Public Health; 2022 Nov; 22(1):2010. PubMed ID: 36324096
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effectiveness of policies for reducing dietary trans fat: a systematic review of the evidence.
    Downs SM; Thow AM; Leeder SR
    Bull World Health Organ; 2013 Apr; 91(4):262-9H. PubMed ID: 23599549
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of WHO recommendations to eliminate industrial trans-fatty acids from the food supply in Latin America and the Caribbean.
    Colón-Ramos U; Monge-Rojas R; Campos H
    Health Policy Plan; 2014 Aug; 29(5):529-41. PubMed ID: 24150503
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Trans fatty acid elimination policy in member states of the Eurasian Economic Union: Implementation challenges and capacity for enforcement.
    Demin A; Løge B; Zhiteneva O; Nishida C; Whiting S; Rippin H; Delles C; Karymbaeva S; Wickramasinghe K; Breda J
    J Clin Hypertens (Greenwich); 2020 Aug; 22(8):1328-1337. PubMed ID: 32677762
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Estimated health benefits, costs and cost-effectiveness of eliminating dietary industrial trans fatty acids in Kenya: cost-effectiveness analysis.
    Marklund M; Aminde LN; Wanjau MN; Huang L; Awuor C; Steele L; Cobb LK; Veerman JL; Wu JH
    BMJ Glob Health; 2023 Oct; 8(10):. PubMed ID: 37848268
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An economic evaluation of salt reduction policies to reduce coronary heart disease in England: a policy modeling study.
    Collins M; Mason H; O'Flaherty M; Guzman-Castillo M; Critchley J; Capewell S
    Value Health; 2014 Jul; 17(5):517-24. PubMed ID: 25128044
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Eliminating artificial trans fatty acids in Argentina: estimated effects on the burden of coronary heart disease and costs.
    Rubinstein A; Elorriaga N; Garay OU; Poggio R; Caporale J; Matta MG; Augustovski F; Pichon-Riviere A; Mozaffarian D
    Bull World Health Organ; 2015 Sep; 93(9):614-22. PubMed ID: 26478625
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trans fatty acids: effects on cardiometabolic health and implications for policy.
    Micha R; Mozaffarian D
    Prostaglandins Leukot Essent Fatty Acids; 2008; 79(3-5):147-52. PubMed ID: 18996687
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changes of trans and saturated fatty acid content in savory baked goods from 2015 to 2021 and their effect on consumers' intake using substitution models: A study conducted in Greece.
    Marakis G; Kotopoulou S; Proestos C; Skoulika S; Boukouvalas G; Papaioannou A; Mousia Z; Papadimitriou D; Katri EM; Naska A; Chourdakis M; Zampelas A; Magriplis E
    Am J Clin Nutr; 2023 Nov; 118(5):1010-1019. PubMed ID: 37640108
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changes in dietary intake and food sources of saturated and cis and trans unsaturated fatty acids in Costa Rican adolescents: 1996 versus 2006.
    Monge-Rojas R; Aragón MC; Chinnock A; Campos H; Colón-Ramos U
    Nutrition; 2013 Apr; 29(4):641-5. PubMed ID: 23298971
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of the regulation on trans fatty acid content in Danish food.
    Leth T; Jensen HG; Mikkelsen AA; Bysted A
    Atheroscler Suppl; 2006 May; 7(2):53-6. PubMed ID: 16713397
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Contribution of Trans-Fatty Acid Intake to Coronary Heart Disease Burden in Australia: A Modelling Study.
    Wu JH; Zheng M; Catterall E; Downs S; Thomas B; Veerman L; Barendregt JJ
    Nutrients; 2017 Jan; 9(1):. PubMed ID: 28106762
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Trans Fatty Acid Levels in Foods and Intakes among Population Aged 3 Years and above in Beijing and Guangzhou Cities, China.
    Liu AD; Li JW; Liu ZP; Zhou PP; Mao WF; Li N; Zhang L
    Biomed Environ Sci; 2015 Jul; 28(7):477-85. PubMed ID: 26248731
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Trans fatty acid contents in selected dietary fats in the Estonian market.
    Meremäe K; Roasto M; Kuusik S; Ots M; Henno M
    J Food Sci; 2012 Aug; 77(8):T163-8. PubMed ID: 22860601
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mandatory trans fat labeling regulations and nationwide product reformulations to reduce trans fatty acid content in foods contributed to lowered concentrations of trans fat in Canadian women's breast milk samples collected in 2009-2011.
    Ratnayake WN; Swist E; Zoka R; Gagnon C; Lillycrop W; Pantazapoulos P
    Am J Clin Nutr; 2014 Oct; 100(4):1036-40. PubMed ID: 25057152
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Updated estimate of trans fat intake by the US population.
    Doell D; Folmer D; Lee H; Honigfort M; Carberry S
    Food Addit Contam Part A Chem Anal Control Expo Risk Assess; 2012; 29(6):861-74. PubMed ID: 22439632
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Impact of Policies to Reduce
    Downs SM; Bloem MZ; Zheng M; Catterall E; Thomas B; Veerman L; Wu JH
    Curr Dev Nutr; 2017 Dec; 1(12):. PubMed ID: 29955689
    [No Abstract]   [Full Text] [Related]  

  • 20. Estimated health benefits, costs and cost-effectiveness of eliminating industrial trans
    Marklund M; Aminde LN; Wanjau MN; Ale BM; Ojo AE; Okoro CE; Adegboye A; Huang L; Veerman JL; Wu JH; Huffman MD; Ojji DB
    BMJ Glob Health; 2024 Apr; 9(4):. PubMed ID: 38631705
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.